Risk Limits in Fair Subject Selection

Affiliations

Comment

Robert Steel. Am J Bioeth. 2020 Feb.

. 2020 Feb;20(2):30-32.

doi: 10.1080/15265161.2019.1701733.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest with respect to the present work.

Four Faces of Fair Subject Selection.
MacKay D, Saylor KW. MacKay D, et al. Am J Bioeth. 2020 Feb;20(2):5-19. doi: 10.1080/15265161.2019.1701731. Am J Bioeth. 2020. Update in: Am J Bioeth. 2020 Feb;20(2):33-35. doi: 10.1080/15265161.2019.1701744. PMID: 31990253 Updated.

1. Daniels N 2007. Just health. Cambridge, NY: Cambridge University Press.
1. Evans D 2017. An activist’s argument that participant values should guide risk-benefit ratio calculations in HIV cure research. Journal of Medical Ethics 43(2): 100–3. - PMC - PubMed
1. Eyal N 2017. The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction. Journal of Medical Ethics 43(2): 65–6. - PMC - PubMed
1. Gianella S, Taylor J, Brown TR, Kaytes A, Achim CL, Moore DJ, Little SJ, J Ellis R, and Smith DM. 2017. Can research at the end-of-life be a useful tool to advance HIV cure? AIDS (London, England) 31(1): 1–4. - PMC - PubMed
1. London AJ 2007. Two dogmas of research ethics and the integrative approach to human-subjects research. The Journal of Medicine and Philosophy 32(2): 99–116. - PubMed